Last updated on: 22/05/2019
1. Contact details
Name of network/collaboration (full name) Development of Robust and Innovative Vaccine Effectiveness
Network/collaboration (short name)DRIVE
Website/homepagewww.drive-eu.org 
Primary contact point of network/collaboration
1) Department/research groupFISABIO/ Vaccine Research Area
2) Organisation/affiliation 
Administrative Contact
Title Mrs
Last name Vázquez-Moreno
First name Mónica
Address line 1Av. Catalunya, 21
Address line 2 
Address line 3 
CityValencia 
Postcode46020 
CountrySpain
Phone number (incl. country code)34-961925948 
Alternative phone number 
Fax number (incl. country code) 
Email address vazquez_monmor@gva.es
Scientific Contact
Title Mr
Last name Javier
First name Díez-Domingo
Address line 1Av. Catalunya, 21
Address line 2 
Address line 3 
CityValencia 
Postcode46020 
CountrySpain
Phone number (incl. country code)34-961925937 
Alternative phone number 
Fax number (incl. country code) 
Email address jdiezdomingo@gmail.com
2. Description
DRIVE (Development of Robust and Innovative Vaccines Effectiveness) is a public private partnership that aims to advance European cooperation in influenza vaccine effectiveness studies. Its partners include public health institutions, universities, small and medium-sized enterprises, vaccine manufacturers, and patient organizations. DRIVE was formed in July 2017 and aims to establish a sufficiently sized network to generate robust, high quality, brand-specific effectiveness estimates for all influenza vaccines used in the EU each season. The data generated through DRIVE is expected to increase the understanding of influenza vaccine effectiveness, lead to enhanced monitoring of influenza vaccine performance by public health institutes and allow manufacturers to fulfil the requirements of the European Medicines Agency (EMA). DRIVE also aims to develop a sustainable and transparent governance model for public private partnerships.
Top